{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:19:59Z","timestamp":1794932399669,"version":"4.9.1"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>Uterine leiomyomas are common and life-altering for many women. Despite a wide range of symptoms, varying characteristics of the uterus and the leiomyomas themselves, and many alternatives, hysterectomy accounts for almost three fourths of all surgical therapy, yet there is increasing evidence for a variety of procedural therapies for symptomatic leiomyomas and a new generation of medical therapies under development. With increasing evidence of long-term risk from hysterectomy and new data regarding leiomyoma biology, individualized medical approaches to leiomyomas are likely in the near future. Key biological attributes that influence this disease process are common driver mutations and the new appreciation of the interaction of smooth muscle cells and fibroblasts. Additionally, the interaction between cell types and steroid hormone responsiveness likely plays a role in pathogenesis that can be leveraged in individualized therapy. However, given the independent clonal nature of leiomyomas within the same uterus, moving in the direction of biopsies for individual leiomyomas to understand the biology is unlikely to be fruitful. Use of advanced imaging will likely continue to evolve not only to accurately predict malignant disease, including sarcomas, but to predict leiomyoma subtypes, response to therapy, or both. We predict the continued evolution of therapy from excisional or interventional therapies to medical therapies and ultimately prediction of at-risk individuals. Ideally, individualized therapies will offer primary prevention for women at high risk of leiomyomas and secondary prevention after initial treatment.<\/jats:p>","DOI":"10.1097\/aog.0000000000002785","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T19:20:12Z","timestamp":1534879212000},"page":"961-971","source":"Crossref","is-referenced-by-count":39,"title":["Moving Toward Individualized Medicine for Uterine Leiomyomas"],"prefix":"10.1097","volume":"132","author":[{"given":"Shannon K.","family":"Laughlin-Tommaso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"16043","DOI":"10.1038\/nrdp.2016.43","article-title":"Uterine fibroids","volume":"2","author":"Stewart","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/jwh.2013.4334","article-title":"The burden of uterine fibroids for African-American women: results of a national survey","volume":"22","author":"Stewart","year":"2013","journal-title":"J Womens Health (Larchmt)"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"492.e1","DOI":"10.1016\/j.ajog.2011.07.008","article-title":"Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends","volume":"205","author":"Wechter","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/GRF.0000000000000164","article-title":"Epidemiology of uterine fibroids: from menarche to menopause","volume":"59","author":"Wise","year":"2016","journal-title":"Clin Obstet Gynecol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"19887","DOI":"10.1073\/pnas.0808188105","article-title":"Growth of uterine leiomyomata among premenopausal black and white women","volume":"105","author":"Peddada","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"38.e1","DOI":"10.1016\/j.ajog.2013.09.038","article-title":"Submucosal fibroids and the relation to heavy menstrual bleeding and anemia","volume":"210","author":"Puri","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.ijcard.2013.03.042","article-title":"Hysterectomy in young women associates with higher risk of stroke: a nationwide cohort study","volume":"168","author":"Yeh","year":"2013","journal-title":"Int J Cardiol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/eurheartj\/ehq477","article-title":"Hysterectomy and risk of cardiovascular disease: a population-based cohort study","volume":"32","author":"Ingelsson","year":"2011","journal-title":"Eur Heart J"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/GME.0000000000001043","article-title":"Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study","volume":"25","author":"Laughlin-Tommaso","year":"2018","journal-title":"Menopause"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1471-0528.2005.00696.x","article-title":"The association of hysterectomy and menopause: a prospective cohort study","volume":"112","author":"Farquhar","year":"2005","journal-title":"BJOG"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.AOG.0000167394.38215.56","article-title":"Ovarian conservation at the time of hysterectomy for benign disease","volume":"106","author":"Parker","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/AOG.0b013e318183fbab","article-title":"Alternatives to hysterectomy in the management of leiomyomas. ACOG Practice Bulletin No. 96. American College of Obstetricians and Gynecologists","volume":"112","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1302736","article-title":"Characterization of uterine leiomyomas by whole-genome sequencing","volume":"369","author":"Mehine","year":"2013","journal-title":"N Engl J Med"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"M\u00e4kinen","year":"2011","journal-title":"Science"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1073\/pnas.1518752113","article-title":"Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers","volume":"113","author":"Mehine","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PGP.0000000000000091","article-title":"Current morphologic criteria perform poorly in identifying hereditary leiomyomatosis and renal cell carcinoma syndrome-associated uterine leiomyomas","volume":"33","author":"Alsolami","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/molehr\/gat083","article-title":"Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues","volume":"20","author":"Holdsworth-Carson","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1158\/0008-5472.CAN-17-1744","article-title":"Subtype-specific tumor-associated fibroblasts contribute to the pathogenesis of uterine leiomyoma","volume":"77","author":"Wu","year":"2017","journal-title":"Cancer Res"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.fertnstert.2011.03.079","article-title":"The FIGO classification of causes of abnormal uterine bleeding in the reproductive years","volume":"95","author":"Munro","year":"2011","journal-title":"Fertil Steril"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ijgo.12266","article-title":"Clinical limitations of the International Federation of Gynecology and Obstetrics (FIGO) classification of uterine fibroids","volume":"139","author":"Laughlin-Tommaso","year":"2017","journal-title":"Int J Gynaecol Obstet"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1067\/mob.2002.121725","article-title":"Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas","volume":"186","author":"Dueholm","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejogrb.2011.11.022","article-title":"Comparison of saline infusion sonohysterography and hysteroscopy in diagnosis of premenopausal women with abnormal uterine bleeding","volume":"161","author":"Soguktas","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jvir.2014.05.012","article-title":"Incidence of additional treatments in women treated with MR-guided focused US for symptomatic uterine fibroids: review of 138 patients with an average follow-up of 2.8 years","volume":"25","author":"Gorny","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2050-5736-1-15","article-title":"Clinical predictors of successful magnetic resonance-guided focused ultrasound (MRgFUS) for uterine leiomyoma","volume":"1","author":"Gorny","year":"2013","journal-title":"J Ther Ultrasound"},{"key":"R28-20230711","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jvir.2013.05.054","article-title":"Apparent diffusion coefficient of uterine leiomyoma as a predictor of the potential response to uterine artery embolization","volume":"24","author":"Lee","year":"2013","journal-title":"J Vasc Interv Radiol"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0000000000001157","article-title":"U.S. Food and Drug Administration's guidance regarding morcellation of leiomyomas: well-intentioned, but is it harmful for women?","volume":"127","author":"Parker","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R30-20230711","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1007\/s00330-013-2819-9","article-title":"How to differentiate benign from malignant myometrial tumours using MR imaging","volume":"23","author":"Thomassin-Naggara","year":"2013","journal-title":"Eur Radiol"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1046\/j.1525-1438.2002.01086.x","article-title":"Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serum determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus","volume":"12","author":"Goto","year":"2002","journal-title":"Int J Gynecol Cancer"},{"key":"R32-20230711","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00330-007-0787-7","article-title":"The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas","volume":"18","author":"Tamai","year":"2008","journal-title":"Eur Radiol"},{"key":"R33-20230711","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1007\/s00261-017-1076-9","article-title":"Magnetic resonance imaging features of uterine sarcoma and mimickers","volume":"42","author":"Barral","year":"2017","journal-title":"Abdom Radiol (NY)"},{"key":"R34-20230711","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ygyno.2008.02.026","article-title":"The utility of preoperative endometrial sampling for the detection of uterine sarcomas","volume":"110","author":"Bansal","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R35-20230711","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/0002-9378(90)91298-Q","article-title":"Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas","volume":"162","author":"Leibsohn","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"R36-20230711","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/01.AOG.0000428646.67925.9a","article-title":"Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Committee Opinion No. 557. American College of Obstetricians and Gynecologists","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R37-20230711","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/2193-1801-3-678","article-title":"Novel uterine sarcoma preoperative diagnosis score predicts the need for surgery in patients presenting with a uterine mass","volume":"3","author":"Nagai","year":"2014","journal-title":"Springerplus"},{"key":"R38-20230711","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1186\/s40064-015-1318-7","article-title":"Highly improved accuracy of the revised PREoperative sarcoma score (rPRESS) in the decision of performing surgery for patients presenting with a uterine mass","volume":"4","author":"Nagai","year":"2015","journal-title":"Springerplus"},{"key":"R39-20230711","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1007\/s00261-017-1314-1","article-title":"Uterine fibroids: correlations between MRI appearance and stiffness via magnetic resonance elastography","volume":"43","author":"Jondal","year":"2018","journal-title":"Abdom Radiol (NY)"},{"key":"R40-20230711","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/humrep\/der369","article-title":"Laparoscopic myomectomy focusing on the myoma pseudocapsule: technical and outcome reports","volume":"27","author":"Tinelli","year":"2012","journal-title":"Hum Reprod"},{"key":"R41-20230711","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejogrb.2012.02.017","article-title":"Uterine fibroid pseudocapsule studied by transmission electron microscopy","volume":"162","author":"Malvasi","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R42-20230711","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2015.01.552","article-title":"Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons","volume":"137","author":"Bakkum-Gamez","year":"2015","journal-title":"Gynecol Oncol"},{"key":"R43-20230711","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale","year":"2014","journal-title":"N Engl J Med"},{"key":"R44-20230711","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/jcp.23.8.676","article-title":"Endometrial changes associated with myomata of the uterus","volume":"23","author":"Deligdish","year":"1970","journal-title":"J Clin Pathol"},{"key":"R45-20230711","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.fertnstert.2009.05.016","article-title":"Endometrial nerve fibers in women with endometriosis, adenomyosis, and uterine fibroids","volume":"92","author":"Zhang","year":"2009","journal-title":"Fertil Steril"},{"key":"R47-20230711","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ejogrb.2012.07.030","article-title":"Therapeutic management of uterine fibroid tumors: updated French guidelines","volume":"165","author":"Marret","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R48-20230711","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijgo.2010.08.009","article-title":"A randomized clinical trial of a levonorgestrel-releasing intrauterine system and a low-dose combined oral contraceptive for fibroid-related menorrhagia","volume":"112","author":"Sayed","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"R49-20230711","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1097\/AOG.0000000000001111","article-title":"Association of the U.S. Food and Drug Administration morcellation warning with rates of minimally invasive hysterectomy and myomectomy","volume":"126","author":"Barron","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R50-20230711","first-page":"186","article-title":"Prospective cohort study of uterine fibroids and miscarriage risk","author":"Hartmann","year":"2017","journal-title":"Am J Epidemiol"},{"key":"R51-20230711","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ajog.2006.02.020","article-title":"Health care resource use for uterine fibroid tumors in the United States","volume":"195","author":"Flynn","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R52-20230711","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"R54-20230711","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.fertnstert.2017.05.006","article-title":"Elagolix for the management of heavy menstrual bleeding associated with uterine fibroids: results from a phase 2a proof-of-concept study","volume":"108","author":"Archer","year":"2017","journal-title":"Fertil Steril"},{"key":"R55-20230711","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1210\/jc.2012-3237","article-title":"Uterine leiomyoma: available medical treatments and new possible therapeutic options","volume":"98","author":"Islam","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R56-20230711","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fonc.2016.00089","article-title":"The end of the hysterectomy epidemic and endometrial cancer incidence: what are the unintended consequences of declining hysterectomy rates?","volume":"6","author":"Temkin","year":"2016","journal-title":"Front Oncol"},{"key":"R57-20230711","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1002\/ijc.30011","article-title":"Long-term cancer risk after hysterectomy on benign indications: population-based cohort study","volume":"138","author":"Altman","year":"2016","journal-title":"Int J Cancer"},{"key":"R58-20230711","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/GME.0000000000000118","article-title":"Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages","volume":"21","author":"Gierach","year":"2014","journal-title":"Menopause"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201810000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:16:25Z","timestamp":1689102985000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201810000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002785","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]}}}